Article

Machine Learning Models Indicate Higher BMI, Older Age Increase Risk for Coronary Heart Disease in Gout

Author(s):

Given the growing evidence that patients with gout are at an increased risk of developing cardiovascular disease, accurately screening patients and identifying potential risk factors is of critical importance.

Several high-risk factors, including older age, a higher body mass index (BMI), and lower creatinine levels were found to be among the main risk factors for developing coronary heart disease (CHD) in patients with gout, according to a study published in Mathematical Biosciences and Engineering.1 Investigators believe that identifying these features may help provide insights into clinical diagnosis.

Machine Learning Models Indicate Higher BMI, Older Age Increases Risk for Coronary Heart Disease in Gout

“Growing evidence shows that there is an increased risk of cardiovascular diseases among gout patients, especially CHD,” investigators explained. “Screening for CHD in gout patients based on simple clinical factors is still challenging.”

Over 300 samples of adult patient with gout were used to build a diagnostic model based on machine learning, a series of algorithm models designed to make predictions or classifications, to avoid both missed diagnoses and exaggerated examinations. The samples were obtained from Jiangxi Provincial People’s Hospital between January 2016 and November 2020. Eligible patients were then placed into 2 groups: gout and gout+CHD.

Investigators focused on 8 clinical indicators for the machine learning classifiers: age, gender, smoking history, BMI, hypertension, nonsteroidal anti-inflammatory drugs (NSAIDs) use, diuretic use, and creatinine levels. These were chosen based on factors that are cost-effective, non-invasive, stable, and easily accessible, enabling the model to be used widely used in hospitals. Eight machine learning models were utilized, including neural networks, support vector machine (SVM), random forest, gradient boosting, such as XGBoost, GBDT, and LightGBM, logistic regression, stepwise logistic regression, and decision tree.

The testing set included 82 samples, with 59 patients placed in the gout+CHD group and 23 in the gout group. Both the SVM and stepwise logistic regression models were able to attain the best under the curve (AUC) values (0.8659 and 0.8508, respectively) when compared with all 8 models, although all models exceeded 0.8.

After performing multiple experiments that randomly split the dataset into the training set and testing set, random forest had the highest accuracy (0.8049) and recall (0.8261), followed by XGBoost (0.7902 and 0.8124, respectively). Although there were significant differences between all 8 models, a Wilcoxon test indicated that there were no significant differences between random forest and XGBoost in terms of recall and accuracy.

According to logistic regression and stepwise logistic regression, older age, a history of smoking, NSAIDs use, hypertension, and lower creatinine levels were significant predictors of gout+CHD. The random forest model, which ranked the mean decrease accuracy of the clinical factors, listed age, BMI, creatinine, NSAIDs, smoking history, and hypertension as the most impactful features. The mean decrease Gini values, also calculated via the random forest model, ranked age, BMI, creatinine, smoking history, NSAIDs, and hypertension among the most important risk factors.

The main limitation of this study is the relatively small number of enrolled patients, thus potentially increasing the risk of sampling errors. Future studies involving larger sample sizes are needed to further test the model.

“We built a diagnostic model for screening CHD in gout patients based on simple clinical factors in this study and found that age, BMI, smoking history and NSAIDs use showed significant effect on predicting CHD, which indicate that gout patients with these risk factors need further cardiac examinations to reveal potential CHD,” investigators concluded. “In the future, it is worthwhile to improve the predictive ability of the diagnostic model by collecting more clinical data and searching for more stable, reliable, and easily available features.”

Reference:

Lili Jiang, Sirong Chen, Yuanhui Wu, Da Zhou, Lihua Duan. Prediction of coronary heart disease in gout patients using machine learning models[J]. Mathematical Biosciences and Engineering, 2023, 20(3): 4574-4591. doi: 10.3934/mbe.2023212

Related Videos
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
4 experts are featured in this series.
4 experts are featured in this series.
A. Sidney Barritt, MD | Credit: UNC School of Medicine
© 2024 MJH Life Sciences

All rights reserved.